Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease

Overview

Journal Int J Behav Med

Publisher Informa Healthcare

Date 2017 Jul 28

PMID 28748378

Citations 12

Authors

Nagwa Essa

Sara Awad

Mariam Nashaat

Affiliations

Soon will be listed here.

Abstract

Purpose: To translate and cross-culturally adapt the Skindex-16, a brief skin-disease-specific QoL questionnaire, into Arabic for Egyptians and to evaluate its measurement properties in Egyptian patients with skin disease.

Method: Translation and cultural adaption were performed following guidelines for cross-cultural adaption of health-related quality of life measures. Subsequently, Skindex-16 was administered to 500 consecutive dermatological patients and 500 healthy persons for verification of its reliability and validity. Next, we examined the effect of skin disorders on QoL as well as influences of age, sex, socioeconomic level, education, and use of medication on skin disease-related QoL.

Results: The instrument showed high internal consistency reliability and good construct and content validity. The quality of life was most deteriorated in the emotional domain followed by symptoms domain (mean percentage score 55.5 ± 23.1 and 31.7 ± 26.8 respectively), while functioning was the least affected domain (mean percentage score 29.1 ± 26.8). Higher total Skindex-16 scores were observed for patients with psoriasis, urticaria, acne, and atopic dermatitis than those with vitiligo and alopecia areata. Educational level, social class, medication use, and family history influenced the impact of skin disease on overall QoL.

Conclusion: The adapted Egyptian Arabic version of Skindex-16 is valid and reliable; it showed that skin problems had a clinically significant impact on QoL in Egyptian patients.

Citing Articles

Patient-Reported Outcome Measures for Mohs Reconstruction: A Systematic Review.

Garg N, Mandloi S, Queenan N, Trivedi J, McCann A, Xu V OTO Open. 2024; 8(4):e70054.

PMID: 39697816 PMC: 11653222. DOI: 10.1002/oto2.70054.

Prevalence and burden of vitiligo in Africa, the Middle East and Latin America.

Hammadi A, Silva de Castro C, Parmar N, Ubogui J, Hatatah N, Ahmed H Skin Health Dis. 2024; 4(1):e317.

PMID: 38312261 PMC: 10831562. DOI: 10.1002/ski2.317.

Being female with vitiligo disease in traditional societies within North Africa.

Raheel M, Snoubar Y, Mosbah W Biopsychosoc Med. 2024; 18(1):1.

PMID: 38200533 PMC: 10777494. DOI: 10.1186/s13030-024-00299-4.

Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs.

Hammadi A, Parmar N, Aljefri K, Al Sharif O, Abdallah M, Ahmed H Dermatol Ther (Heidelb). 2023; 13(7):1435-1464.

PMID: 37338721 PMC: 10307736. DOI: 10.1007/s13555-023-00946-8.

Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis.

van Dalen M, Muller K, Kasperkovitz-Oosterloo J, Okkerse J, Pasmans S Front Med (Lausanne). 2022; 9:1054898.

PMID: 36523776 PMC: 9745337. DOI: 10.3389/fmed.2022.1054898.

References

Kleinman A, EISENBERG L, Good B . Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978; 88(2):251-8. DOI: 10.7326/0003-4819-88-2-251. View

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

Guillemin F, Bombardier C, Beaton D . Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993; 46(12):1417-32. DOI: 10.1016/0895-4356(93)90142-n. View

Mokkink L, Terwee C, Patrick D, Alonso J, Stratford P, Knol D . The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010; 19(4):539-49. PMC: 2852520. DOI: 10.1007/s11136-010-9606-8. View

Chernyshov P . Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity. G Ital Dermatol Venereol. 2014; 151(1):37-43. View

Prinsen C, Lindeboom R, Sprangers M, Legierse C, de Korte J . Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol. 2009; 130(5):1318-22. DOI: 10.1038/jid.2009.404. View

Sampogna F, Spagnoli A, Di Pietro C, Pagliarello C, Paradisi A, Tabolli S . Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients. J Invest Dermatol. 2012; 133(1):104-9. DOI: 10.1038/jid.2012.244. View

Jobanputra R, Bachmann M . The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol. 2000; 39(11):826-31. DOI: 10.1046/j.1365-4362.2000.00073.x. View

He Z, Lu C, Chren M, Zhang Z, Li Y, Ni X . Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014; 12:190. PMC: 4305222. DOI: 10.1186/s12955-014-0190-4. View

10.

Abolfotouh M, Al-Khowailed M, Suliman W, Al-Turaif D, Al-Bluwi E, Al-Kahtani H . Quality of life in patients with skin diseases in central Saudi Arabia. Int J Gen Med. 2012; 5:633-42. PMC: 3410718. DOI: 10.2147/IJGM.S33276. View

11.

Kosaraju S, Reddy K, Vadlamani N, Sandhya L, Kalasapati L, Maganti S . Psychological Morbidity Among Dermatological Patients in a Rural Setting. Indian J Dermatol. 2015; 60(6):635. PMC: 4681219. DOI: 10.4103/0019-5154.169140. View

12.

Tabolli S, Pagliarello C, Di Pietro C, Abeni D . Limited role of marital status in the impact of dermatological diseases on quality of life. Eur J Dermatol. 2012; 22(5):672-7. DOI: 10.1684/ejd.2012.1822. View

13.

Leeyaphan C, Wanitphakdeedecha R, Manuskiatti W, Kulthanan K . Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population. BMC Dermatol. 2011; 11:16. PMC: 3280162. DOI: 10.1186/1471-5945-11-16. View

14.

Radtke M, Schafer I, Gajur A, Langenbruch A, Augustin M . Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009; 161(1):134-9. DOI: 10.1111/j.1365-2133.2009.09091.x. View

15.

Al Robaee A . Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J. 2007; 28(9):1414-7. View

16.

Zachariae R, Zachariae C, Ibsen H, Mortensen J, Wulf H . Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004; 84(3):205-12. DOI: 10.1080/00015550410023284. View

17.

Chren M . The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012; 30(2):231-6, xiii. PMC: 3269028. DOI: 10.1016/j.det.2011.11.003. View

18.

El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi F . Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatolog Treat. 2012; 25(2):106-9. DOI: 10.3109/09546634.2012.681016. View

19.

Gurel M, Yanik M, Simsek Z, Kati M, Karaman A . Quality of life instrument for Turkish people with skin diseases. Int J Dermatol. 2005; 44(11):933-8. DOI: 10.1111/j.1365-4632.2004.02225.x. View

20.

Lundberg L, Johannesson M, Silverdahl M, HERMANSSON C, Lindberg M . Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2001; 80(6):430-4. DOI: 10.1080/000155500300012873. View